End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
550 KRW | -1.08% |
|
-15.12% | -80.97% |
2023 | CELLGENTEK Co., Ltd. announced that it has received KRW 1.27795162 billion in funding | CI |
2023 | CELLGENTEK Co., Ltd. announced that it expects to receive KRW 1.27795162 billion in funding | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Custom Manufacturing of Analysis Devices and Systems
96.7
%
| 20,558 | 97.3 % | 13,926 | 96.7 % | -32.26% |
Other Services
3.3
%
| 558 | 2.6 % | 470 | 3.3 % | -15.73% |
Medical Analysis Equipment and Systems
0.1
%
| 11 | 0.1 % | 8 | 0.1 % | -25.38% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 21,126 | 100.0 % | 14,404 | 100.0 % | -31.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hoi-Yul Kim
CEO | Chief Executive Officer | 48 | - |
Woo-Jung Son
BRD | Director/Board Member | 63 | - |
Eun-Ho Lee
AUD | Comptroller/Controller/Auditor | 51 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Suk-Gil Song
BRD | Director/Board Member | 59 | - |
Hoi-Yul Kim
CEO | Chief Executive Officer | 48 | - |
Sook-Ryong Ma
BRD | Director/Board Member | 58 | - |
Woo-Jung Son
BRD | Director/Board Member | 63 | - |
Geun-Jae Lee
BRD | Director/Board Member | 65 | - |
Gyeong-Eun Lee
BRD | Director/Board Member | 47 | - |
Hu-Gyun Choi
BRD | Director/Board Member | 70 | - |
In-Tak Yoo
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,989,375 | 3,659,176 ( 73.34 %) | 0 | 73.34 % |
Company contact information
Cellgentek Co., Ltd.
110-6 Osongsaengmyeong 2-ro Osong-eup
28161, Cheongju-si
+
http://www.cellgentek.co.kr![address CELLGENTEK Co., Ltd.(A258250)](https://cdn.zonebourse.com/static/address/120973768.png)
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-80.97% | 1.56M | |
+36.94% | 398B | |
+34.21% | 235B | |
+11.24% | 161B | |
+23.07% | 62.86B | |
+31.45% | 37.81B | |
+2.03% | 30.19B | |
+106.15% | 23.1B | |
+28.07% | 21.62B | |
+38.61% | 14.05B |
- Stock Market
- Equities
- A258250 Stock
- Company CELLGENTEK Co., Ltd.